METROPOLITAN LIFE INSURANCE CO/NY - CYTEK BIOSCIENCES INC ownership

CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 102 filers reported holding CYTEK BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of CYTEK BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$41,339
-27.7%
7,489
+11.8%
0.00%
-33.3%
Q2 2023$57,184
-1.1%
6,696
+6.4%
0.00%0.0%
Q1 2023$57,814
-20.1%
6,291
-11.2%
0.00%0.0%
Q4 2022$72,317
-30.6%
7,0830.0%0.00%
-40.0%
Q3 2022$104,262
+37.2%
7,0830.0%0.01%
+66.7%
Q2 2022$76,001
+9.9%
7,083
+10.4%
0.00%
+50.0%
Q1 2022$69,154
-13.2%
6,415
+31.5%
0.00%
+100.0%
Q4 2021$79,625
-23.8%
4,8790.0%0.00%
-50.0%
Q3 2021$104,4594,8790.00%
Other shareholders
CYTEK BIOSCIENCES INC shareholders Q2 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,100,000$30,912,00012.48%
Miura Global Management 820,000$12,070,0007.24%
RA Capital Management 13,381,054$196,969,0004.20%
HHLR ADVISORS, LTD. 8,757,030$128,903,0003.39%
Brown Capital Management 4,406,461$64,863,0000.91%
Perceptive Advisors 1,289,534$18,982,0000.55%
Hillsdale Investment Management Inc. 344,529$5,072,0000.46%
PURA VIDA INVESTMENTS, LLC 527,164$7,760,0000.45%
Parkwood LLC 42,336$623,0000.09%
PDT Partners, LLC 31,436$463,0000.07%
View complete list of CYTEK BIOSCIENCES INC shareholders